SUBSCRIBE
SUBSCRIBE

Preclinical

Drug Development
2021 Biopharma Update on the Novel Coronavirus: February 2
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for February 2, 2021.
February 2, 2021
 · 
5 min read
 · 
BioSpace Editorial Staff
Drug Development
Elevian Targets Aging to Solve Humanity’s Toughest Diseases
Elevian believes that this single protein, a key player in the circulatory system, could be a game-changer in regenerative medicine.
January 29, 2021
 · 
6 min read
 · 
Heather McKenzie
Drug Development
Genocea’s ATLAS Platform May Be Game Changer in Cancer Immunotherapy
While the ATLAS platform has the potential to lead to an effective vaccine in itself, its greatest impact in the field of immunotherapy may be that it offers a new way of understanding how a tumor evades the therapy’s boundaries by identifying bad Inhibigens that lead to suppressive, or inhibitory, responses.
January 28, 2021
 · 
3 min read
 · 
Heather McKenzie
Drug Development
2021 Biopharma Update on the Novel Coronavirus: January 26
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for January 26, 2021.
January 26, 2021
 · 
4 min read
 · 
BioSpace Editorial Staff
Drug Development
2021 Biopharma Update on the Novel Coronavirus: January 19
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for January 19, 2021.
January 19, 2021
 · 
6 min read
 · 
BioSpace Editorial Staff
Keitma/Shutterstock
Business
Sanofi Keeps on Rolling With Biond Biologics Partnership
The novel immune checkpoint inhibitor Sanofi deemed worthy of such an investment is BND-22, a humanized IgG4 antagonist antibody targeting the Ig-like transcript 2 (ILT2) receptor, an inhibitory receptor expressed on both innate and adaptive immune cells.
January 12, 2021
 · 
3 min read
 · 
Heather McKenzie
Drug Development
2021 Biopharma Update on the Novel Coronavirus: January 12
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for January 12, 2021.
January 12, 2021
 · 
4 min read
 · 
BioSpace Editorial Staff
Drug Development
2021 Biopharma Update on the Novel Coronavirus: January 5
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for January 5, 2021.
January 4, 2021
 · 
3 min read
 · 
BioSpace Editorial Staff
Drug Development
Biopharma Update on the Novel Coronavirus: December 29
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for December 29, 2020.
December 22, 2020
 · 
2 min read
 · 
BioSpace Editorial Staff
Policy
Biopharma Update on the Novel Coronavirus: December 22
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for December 22, 2020.
December 22, 2020
 · 
4 min read
 · 
BioSpace Editorial Staff
Load More
PRESS RELEASES
Press Releases
Siolta Therapeutics and Cowellnex Enter Joint Research Agreement
January 29, 2025
 · 
2 min read
Press Releases
Silexion Therapeutics Reports Strong Tumor Growth Reduction from Systemic Administration of SIL-204 in Preclinical Pancreatic Cancer Models
January 29, 2025
 · 
4 min read
Press Releases
Telomir Pharmaceuticals Announces Breakthrough Results With Telomir-1 Fully Reversing Oxidative Stress in Human Cell Lines and Exploring Potential as a Treatment for Avian Influenza (Bird Flu) and Other Viruses
January 28, 2025
 · 
8 min read
Press Releases
Gossamer Bio to Present Clinical and Preclinical Data at the Pulmonary Vascular Research Institute 2025 Annual Congress
January 28, 2025
 · 
5 min read
Press Releases
Hyundai ADM Unveils a “New Paradigm in Cancer Treatment” - Preclinical Study Shows Promise for Continuous Oral Chemotherapy with Lowered Side Effects Risks
January 22, 2025
 · 
4 min read
Press Releases
PESG Market Update: Silexion Therapeutics’ SIL-204 Shows Groundbreaking Synergy in Preclinical Data, Boosting Hope for KRAS-Driven Cancer Treatments
January 17, 2025
 · 
2 min read
Press Releases
Silexion Therapeutics Announces Additional Promising Preclinical Data for SIL-204, Demonstrating Impressive Synergy with First-Line Pancreatic Cancer Chemotherapies
January 16, 2025
 · 
5 min read
Press Releases
Eterna Therapeutics Announces Positive Preclinical Study Results on Lead Product ERNA-101 in Ovarian Cancer
January 15, 2025
 · 
5 min read
Press Releases
Menarini Group and Insilico Medicine Enter a Second Exclusive Global License Agreement for an AI Discovered Preclinical Asset Targeting High Unmet Needs in Oncology
January 10, 2025
 · 
5 min read
Press Releases
TAE Life Sciences and Kyoto University Achieve Breakthrough Preclinical Results in Boron Neutron Capture Therapy (BNCT) with Promising Implications for Cancer Treatment
January 9, 2025
 · 
3 min read
Press Releases
TriSalus Life Sciences® Announces Publication of Pre-Clinical Data Demonstrating Improved Delivery of Embospheres® to Liver Tumors using Pressure-Enabled Drug Delivery™ (PEDD™) via the TriNav® Infusion System
January 9, 2025
 · 
5 min read
Press Releases
Cyrus Biotechnology Announces Selection of CYR212 as Clinical Candidate for Chronic IgG-driven Autoimmune Disease Including Myasthenia Gravis and Immune Thrombocytopenia
January 9, 2025
 · 
5 min read
Press Releases
Instem Introduces Cloud-Hosted Non-GLP Pathology Module for Provantis
January 8, 2025
 · 
2 min read
Press Releases
Biomea Fusion Reports New Preclinical Data on Icovamenib-Semaglutide Combination Study
January 8, 2025
 · 
9 min read
Press Releases
Rakovina Therapeutics Announces Receipt of AI-Derived Drug Candidates and Advancement to Preclinical Validation
January 6, 2025
 · 
6 min read
Press Releases
Channel Therapeutics Announces Positive Efficacy Data For a Depot Formulation of a NaV1.7 Inhibitor in a Preclinical In Vivo Nerve Block Model
December 18, 2024
 · 
5 min read
Press Releases
BioVaxys Secures GMP-Grade Lipid Supply for Production of DPX-Based Vaccines in Advance of Preclinical and Clinical Program Ramp-Up
December 17, 2024
 · 
5 min read
Press Releases
enVVeno Medical Successfully Completes Final Wave of Implants in Pre-Clinical GLP Study for enVVe
December 16, 2024
 · 
5 min read
Press Releases
4DMT Announces Landmark Publication of 4D-150 Preclinical Data for the Treatment of Neovascular Retinopathies in IOVS
December 16, 2024
 · 
8 min read
Press Releases
Esperovax Awarded Subcontract for Development of Thermostable Oral Vaccine Platform
December 13, 2024
 · 
2 min read
Load More